US2020100793A1PendingUtilityA1
Devices and methods for treating acute kidney injury
Est. expiryMay 4, 2036(~9.8 yrs left)· nominal 20-yr term from priority
A61B 17/12036A61M 2210/1082A61B 17/12172A61M 25/1011A61B 17/12109A61B 17/12031A61B 2090/3966A61B 17/1204A61M 2205/3327A61M 2210/12A61B 90/06A61M 2025/1079A61B 6/484A61M 2205/0266A61M 2025/1095A61B 17/12045A61B 17/12136A61B 17/12131A61B 6/12A61B 2017/00455A61B 2090/063A61M 2025/0073A61M 2205/0244A61M 25/09A61B 2090/064A61M 25/0108A61M 2025/1052A61M 2025/0002A61M 5/007A61M 2206/16A61M 2205/3331A61M 25/1002A61M 60/33A61M 60/531A61M 60/295A61M 60/13A61M 60/427A61M 60/554
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A catheter devices/systems and methods therefrom are described herein for treating acute kidney injury, especially the contrast-induced acute kidney injury wherein the devices may prevent the contrast dyes from entering into kidney and/or facilitate blood flow of kidney by said catheter system.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of preventing acute kidney injury from contrast agent introduced into vasculature of a subject, the method comprising:
positioning a proximal portion of a catheter device comprising a catheter shaft and an occlusive element in an abdominal aorta of the subject adjacent renal artery ostia of the subject, wherein one or more longitudinal position indication features are disposed on the occlusive element; deploying the occlusive element of the catheter device to occlude the renal artery ostia; confirming occlusion of the renal artery ostia when the occlusive element is deployed by observing the appearance of the one or more longitudinal position indication features; introducing a bolus of the contrast agent into the abdominal aorta of the subject while the occlusive element is deployed to occlude the renal artery ostia, thereby preventing the contrast agent from entering into renal arteries of the subject; and collapsing the occlusive element after the bolus of the contrast agent has been introduced, thereby allowing blood flow to the renal arteries to resume.
2 . The method of claim 1 , wherein positioning the proximal portion of the catheter device comprises observing a position of one or more position indication features and positioning the proximal portion of the catheter device in response to the observed position.
3 . The method of claim 2 , wherein the one or more position indication features comprise a radio-opaque marker, and wherein observing the one or more position indication feature is done using x-ray imaging.
4 . The method of claim 1 , wherein confirming occlusion of the renal artery ostia comprising observing the appearance of a bowed section in the one or more longitudinal position indication features.
5 . The method of claim 1 , wherein the one or more longitudinal position indication features comprises one or more longitudinal radio-opaque markers and wherein the bowed section is observed using x-ray imaging.
6 . The method of claim 1 , wherein positioning the proximal portion of the catheter device comprises observing a orientation of an orientation element disposed on a distal portion of the catheter device and positioning the proximal portion of the catheter device in response to the observed orientation, wherein the orientation element is aligned with the occlusive element and configured to indicate the orientation of the occlusive element when positioned adjacent renal artery ostia of the subject.
7 . The method of claim 1 , wherein the occlusive element comprises a first expandable member disposed on a first lateral side of the proximal portion and a second expandable member disposed on a second lateral side of the proximal portion, wherein deploying the occlusive element comprises expanding the first and second expandable members, and wherein collapsing the occlusive element comprises collapsing the first and second expandable members.
8 . The method of claim 1 , wherein expanding the first and second expandable members comprises simultaneously expanding the first and second expandable members.
9 . The method of claim 1 , wherein collapsing the occlusive element comprises collapsing the occlusive element after a pre-determined amount of time.
10 . The method of claim 1 , wherein deploying the occlusive element and introducing the bolus of the contrast agent are synchronized.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.